FONT-SIZE Plus   Neg

Mylan, Pfizer To Settle Litigation Relating To Detrol - Quick Facts

Mylan Inc. (MYL) announced that the company and its subsidiary, Mylan Pharmaceuticals Inc., inked a settlement agreement with Pfizer Inc. (PFE), Pharmacia & Upjohn Co. LLC and Pfizer Health AB that will resolve the parties' patent litigation in connection with Mylan Pharmaceuticals' Abbreviated New Drug Application, or ANDA, for Tolterodine Tartrate ER capsules, 2 mg and 4 mg, which is the generic version of Pfizer's Detrol LA, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

As per the terms of the settlement agreement, Mylan may start selling the product on January 1, 2014, or earlier under certain limited circumstances, and no later than March 1, 2014, subject to final approval from the U.S. Food and Drug Administration. Under the terms of the agreement, Mylan may launch the product as either an authorized generic or under its own ANDA. Pursuant to the agreement, the pending litigation will be dismissed.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Buick, Lexus and Toyota are among the top brands with highest reliability rating in the latest annual brand reliability survey. A New York woman has filed a $20 million lawsuit against Kentucky Fried Chicken, accusing the fast-food giant of 'false and deceptive trade practice' and also of misleading customers as she did not get enough chicken in her $20 "Fill-Up." Fans of Girl Scouts Cookies can rejoice. General Mills Inc. has confirmed its plans to launch two cereals inspired by Girl Scout cookies next year. The cereals will come in two flavors and in boxes carrying the Girl Scouts logo.
comments powered by Disqus
Follow RTT